Virginia diabetes and endo1/17/2024 ![]() Rita Basu, MD, is a clinical researcher who co-directs the Integrated Carbohydrate Physiology and Translation Laboratory. Basu now directs our newly renewed T32 grant (“Research Training in Neuroendocrinology and Metabolism”). He also served on the DSMB for the RADIANT study (NIH/NIDDK) and delivered a presentation at the International Diabetes Summit (Chellaram Diabetes Institute, Pune, India). Basu had at least six peer-reviewed publications in 2022. He also served as an essential Co-Investigator for two R01s and several industry-sponsored trials. Basu’s 2022 research was funded by R01 DK085516 (A Basu PI – “Integrated Approaches to Close the Loop in Type 1 Diabetes”). His areas of research interest include automated insulin delivery systems, glucagon kinetics, etc. Barrett can be found elsewhere in this newsletter.Īnanda Basu, MD, is a clinician-investigator and diabetologist who co-directs the Integrated Carbohydrate Physiology and Translation Laboratory. Afreen is a member of the Obesity Medicine Association’s Adult Obesity Algorithm Committee, CME Overview Committee, and the American Association of Clinical Endocrinology’s Diabetes, Cardiometabolic, and Lipid Disease State Network Committee.Įugene Barrett, MD, PhD, retired at the end of November 2022 after a long and remarkably productive career. She is certified by both ABIM and the American Board of Obesity Medicine. Afreen is a general endocrinologist with a special interest in metabolic bone disease, obesity, and diabetes technology. From 2019 to 2022, she worked as an endocrinologist at the Center for Diabetes and Endocrine Health, Allegheny Clinic, in Erie, PA she was also an Assistant Professor of Medicine at Drexel College of Medicine. ![]() She completed her internship and residency at Howard University and her endocrinology fellowship at the University of Pittsburgh Medical Center. Afreen graduated from Calcutta Medical College of Medicine (India) in 2009. Samina Afreen, MD, is our newest faculty member, joining us in September 2022. My very best wishes for a happy and healthy 2023! As with last year, I employ this edition of Medicine Matters to honor my fellow division members, who have significantly contributed to our various missions. (As a group, our divisional faculty, staff, etc., have been exceptionally supportive of me as interim division chief, and they’ll have my unremitting gratitude.) The past year has also been marked by early-/mid-career faculty success with milestone grant funding (e.g., three career-development awards, a first R01). We’re also approaching the conclusion of a national search for a permanent division chief: the candidates we’ve hosted have been extraordinary, and I’m highly optimistic that our next chief will be an outstanding addition to our division. The endocrine division continued to face several challenges in 2022-primarily related to reduced clinician capacity-although we’re happy to report a number of recent hires. McCartney MD, Endocrinology and Metabolism Interim Division Chief Christopher McCartney Message from Christopher R. Plastic Surgery, Maxillofacial, & Oral Healthĭr.Translational Health Research Institute of Virginia.Institute of Law, Psychiatry & Public Policy.Child Health Research Center (Pediatrics).Thaler Center for AIDS & Human Retrovirus Research Center for Immunity, Inflammation & Regenerative Medicine.Center for Behavioral Health & Technology.Molecular Physiology & Biological Physics.Microbiology, Immunology, & Cancer Biology (MIC).
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |